Cognitive Rehabilitation

  • Chiara Zucchella


Increased life expectancy in patients with brain tumours has led to a greater risk of cognitive deficits across many domains, that reduce patients’ autonomy and participation, with a deep impact on patients’ and caregivers’ quality of life.

Cognitive rehabilitation interventions, that exploit the plastic properties of the brain to reorganize after an injury, have been proven to be useful in the treatment of cognitive deficits in various populations of patients with other neurological disorders; conversely, studies investigating the effectiveness of cognitive rehabilitation in neuro-oncological population are few. Although still preliminary, however, evidence suggests that multidisciplinary approaches to rehabilitation that encompasses adaptive, remedial, functional, and metacognitive interventions can optimize cognitive outcome of neuro-oncological patients and occur in parallel with disease-centred, medical management. In this area interest is growing hand in hand with the awareness that long-term treatment and disease-related morbidity can’t be neglected and that measures of health-related quality of life are important outcome measures for brain tumour patients, complementing traditional measures of survival or disease stability.


  1. 1.
    Back M, Back E, Kastelan M, Wheeler H. Cognitive deficits in primary brain tumours: a framework for management and rehabilitation. J Cancer Ther. 2014;5:74–81.CrossRefGoogle Scholar
  2. 2.
    Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised Phase III study: 5-year analysis of the EORTC-NCIC Trial. Lancet Oncol. 2009;10(5):459–66.PubMedCrossRefGoogle Scholar
  3. 3.
    Cairncross G, Wang M, Shaw E, Jenkins R, Brachman D, Buckner J, et al. Phase III trial of chemoradiotherapy for anaplasticoligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 2013;31(3):337–43.PubMedCrossRefGoogle Scholar
  4. 4.
    van den Bent MJ, Brandes AA, Taphoorn MJ, Kros JM, Kouwenhoven MC, Delattre JY, et al. Adjuvant procarbazine, lomustine, and vincristine chemo- therapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumour group study 26951. J Clin Oncol. 2013;31(3):344–50.PubMedCrossRefGoogle Scholar
  5. 5.
    Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3:159–68.PubMedCrossRefGoogle Scholar
  6. 6.
    Fliessbach K, Rogowski S, Hoppe C, Sabel M, Goeppert M, Helmstaedter C, et al. Computer-based assessment of cognitive functions in brain tumor patients. J Neurooncol. 2010;100:427–37.PubMedCrossRefGoogle Scholar
  7. 7.
    Bergo E, Lombardi G, Pambuku A, Della Puppa A, Bellu L, D’Avella D, et al. Cognitive rehabilitation in patients with gliomas and other brain tumors: state of the art. Biomed Res Int. 2016;2016:3041824. Scholar
  8. 8.
    Giovagnoli AR. Investigation of cognitive impairments in people with brain tumors. J Neurooncol. 2012;108(2):277–83.PubMedCrossRefGoogle Scholar
  9. 9.
    Monje M, Dietrich J. Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behav Brain Res. 2012;227(2):376–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Gehrke AK, Baisley MC, Sonck ALB, Wronski SL, Feuerstein M. Neurocognitive deficits following primary brain tumour treatment: systematic review of a decade of comparative studies. J Neurooncol. 2013;115(29):135–42.PubMedCrossRefGoogle Scholar
  11. 11.
    Day J, Gillespie DC, Rooney AG, Bulbeck HJ, Zienius K, Boele F, et al. Neurocognitive deficits and neurocognitive rehabilitation in adult brain tumours. Curr Treat Options Neurol. 2016;18(5):22.PubMedCrossRefGoogle Scholar
  12. 12.
    Tucha O, Smely C, Preier M, Lange KW. Cognitive deficits before treatment among patients with brain tumours. Neurosurgery. 2000;47:324–33.PubMedCrossRefGoogle Scholar
  13. 13.
    Klein M, Taphoorn MJ, Heimans JJ, van der Ploeg HM, Vandertop WP, Smit EF, et al. Neurobehavioural status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol. 2001;19:4037–47.PubMedCrossRefGoogle Scholar
  14. 14.
    Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, et al. Neurocognitive function and progression in patients with brain metastases treated with wholebrain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004;22:157–65.PubMedCrossRefGoogle Scholar
  15. 15.
    van Nieuwenhuizen D, Klein M, Stalpers LJ, Leenstra S, Heimans JJ, Reijneveld JC. Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol. 2007;84:271–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Zucchella C, Bartolo M, Di Lorenzo C, Villani V, Pace A. Cognitive impairment in primary brain tumors outpatients: a prospective cross-sectional survey. J Neuro-Oncol. 2013;112(3):455–60.CrossRefGoogle Scholar
  17. 17.
    Bosma I, Vos MJ, Heimans JJ, Taphoorn MJ, Aaronson NK, Postma TJ, et al. The course of neurocognitive functioning in high-grade glioma patients. Neuro-Oncology. 2007;9(1):53–62.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Correa DD. Neurocognitive function in brain tumours. Curr Neurol Neurosci Rep. 2010;10:232–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Kayl AE, Meyers CA. Does brain tumour histology influence cognitive function? Neuro Oncology. 2003;5:255–60.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC. Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumours. Int J Radiat Oncol Biol Phys. 2003;55:992–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Correa DD, Shi W, Thaler HT, Cheung AM, DeAngelis LM, Abrey LE. Longitudinal cognitive follow-up in low grade gliomas. J Neurooncol. 2008;86:321–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Ius T, Angelini E, Thiebaut de Schotten M, Mandonnet E, Duffau H. Evidence for potentials and limitations of brain plasticity using an atlas of functional resectability of WHO grade II gliomas: towards a “minimal common brain”. NeuroImage. 2011;56:992–1000.PubMedCrossRefGoogle Scholar
  23. 23.
    Meyers CA, Hess KR. Multifaceted end points in brain tumour clinical trials: cognitive deterioration precedes MRI progression. Neuro-oncology. 2003;5:89–95.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Armstrong CL, Goldstein B, Shera D, Ledakis GE, Tallent EM. The predictive value of longitudinal neuropsychologic assessment in the early detection of brain tumour recurrence. Cancer. 2003;97:649–56.PubMedCrossRefGoogle Scholar
  25. 25.
    Duffau H. Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity. Lancet Neurol. 2005;4:476–86.PubMedCrossRefGoogle Scholar
  26. 26.
    Sheline G, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Rad Oncol Biol Phys. 1980;6:1215–28.CrossRefGoogle Scholar
  27. 27.
    Surma-aho O, Niemela M, Vilkki J, Kouri M, Brander A, Salonen O, et al. Adverse long-term effects of brain radiotherapy in adult lowgrade glioma patients. Neurology. 2001;56:1285–90.PubMedCrossRefGoogle Scholar
  28. 28.
    Postma TJ, Klein M, Verstappen CC, Bromberg JE, Swennen M, Langendijk JA, et al. Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology. 2002;59:121–3.PubMedCrossRefGoogle Scholar
  29. 29.
    Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-Oncology. 2013;15(10):1429–37.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol. 2017;13(1):52–64.PubMedCrossRefGoogle Scholar
  31. 31.
    Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and vivo. J Biol. 2006;5(7):22.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist. 2008;13:1285–95.PubMedCrossRefGoogle Scholar
  33. 33.
    Saykin AJ, Ahles TA, McDonald BC. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry. 2003;8:201–16.PubMedCrossRefGoogle Scholar
  34. 34.
    Abrey LE. The impact of chemotherapy on cognitive outcomes in adults with primary brain tumours. J Neurooncol. 2012;108:285–90.PubMedCrossRefGoogle Scholar
  35. 35.
    Anderson SI, Taylor R, Whittle IR. Mood disorders in patients after treatment for primary intracranial tumours. Br J Neurosurg. 1999;13:480–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Piil K, Jarden M, Jakobsen J, Christensen KB, Juhler M. A longitudinal, qualitative and quantitative exploration of daily life and need for rehabilitation among patients with high-grade gliomas and their caregivers. BMJ Open. 2013;3(7):e003183.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    World Health Organization. International classification of functioning, disability, and health (ICF). Geneva: WHO; 2001.Google Scholar
  38. 38.
    Aaronson NK. Quality of life: what is it? How should it be measured? Oncology (Williston Park). 1988;2(5):69–76.PubMedGoogle Scholar
  39. 39.
    Dirven L, Reijneveld JC, Aaronson NK, Bottomley A, Uitdehaag BMJ, Taphoorn MJ. Health-related quality of life in patients with brain tumours: limitations and additional outcome measures. Curr Neurol Neurosci Rep. 2013;13(7):359.PubMedCrossRefGoogle Scholar
  40. 40.
    Cheng J, Zhang X, Liu BL. Health-related quality of life in patients with high-grade glioma. Neuro-Oncology. 2009;11(1):41–50.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Bosma I, Reijneveld JC, Douw L, Vos MJ, Postma TJ, Aaronson NK, et al. Health-related quality of life of long-term high-grade glioma survivors. Neuro-Oncology. 2009;11(1):51–8.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Veilleux N, Goffaux P, Boudrias M, Mathieu D, Daigle K, Fortin D. Quality of life in neurooncology—age matters. J Neurosurg. 2010;113:325–32.PubMedCrossRefGoogle Scholar
  43. 43.
    Giovagnoli AR, Meneses RF, Silvani A, Milanesi I, Fariselli L, Salmaggi A, et al. Quality of life and brain tumours: what beyond the clinical burden? J Neurol. 2014;261:894–904.PubMedCrossRefGoogle Scholar
  44. 44.
    McLellan DL. Functional recovery and the principles of disability medicine. In: Swash M, Oxbury J, editors. Clinical neurology. Edinburgh, UK: Churchill Livingstone; 1991. p. 768–90.Google Scholar
  45. 45.
    Harley JP, Allen C, Braciszewski TL, Cicerone KD, Dahlberg C, Evans S, et al. Guidelines for cognitive rehabilitation. Neurorehabilitation. 1992;2(3):62–7.Google Scholar
  46. 46.
    Wilson BA. Cognitive rehabilitation: how it is and how it might be. J Int Neuropsychol Soc. 1997;3(5):487–96.PubMedCrossRefGoogle Scholar
  47. 47.
    Katz DI, Ashley M, O’Shanick GJ, Connors SH. Cognitive rehabilitation: the evidence, the funding and case for advocacy in brian injury. Mc Lean, VA: Brain Injury Association of America; 2006.Google Scholar
  48. 48.
    Cicerone KD, Langenbahn DM, Braden C, Malec JF, Kalmar K, Fraas M, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Arch Phys Med Rehabil. 2011;92(4):519–30.PubMedCrossRefGoogle Scholar
  49. 49.
    Wilson BA. Neuropsychological Rehabilitation. Annu. Rev. Clin. Psychol. 2008;4:141–62.PubMedCrossRefGoogle Scholar
  50. 50.
    Sohlberg M, Mateer C. Introduction to cognitive rehabilitation theory and practice. New York: The Guilford Press; 1989.Google Scholar
  51. 51.
    Vargo M. Brain tumour rehabilitation. Am J Phys Med Rehabil. 2011;90(5):S50–62.PubMedCrossRefGoogle Scholar
  52. 52.
    Nair KT, Wade DT. Satisfaction of members of interdisciplinary rehabilitation teams with goal planning meetings. Arch Phys Med Rehabil. 2003;84(11):1710–3.PubMedCrossRefGoogle Scholar
  53. 53.
    Sohlberg M, Mateer C. Cognitive rehabilitation: an integrative neuropsychological approach. New York: The Guildford Press; 2001.Google Scholar
  54. 54.
    Society for Cognitive Rehabilitation, “What Is Cognitive Rehabilitation?” 2013.
  55. 55.
    Gehring K, Sitskoorn MM, Aaronson NK, Taphoorn MJB. Interventions for cognitive deficits in adults with brain tumours. Lancet Neurol. 2008;7:548–60.PubMedCrossRefGoogle Scholar
  56. 56.
    Rao SM, Bieliauskas LA. Cognitive rehabilitation two and one-half years post right temporal lobectomy. J Clin Neuropsychol. 1983;5:313–20.PubMedCrossRefGoogle Scholar
  57. 57.
    Sherer M, Meyers CA, Bergloff P. Efficacy of postacute brain injury rehabilitation for patients with primary malignant brain tumours. Cancer. 1997;80:250–7.PubMedCrossRefGoogle Scholar
  58. 58.
    Locke DEC, Cerhan JH, Wu W, Malec JF, Clark MM, Rummans TA, et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumours: a pilot study. J Support Oncol. 2008;6:383–91.PubMedGoogle Scholar
  59. 59.
    Gehring K, Sitskoorn MM, Gundy CM, Sikkes SA, Klein M, Postma TJ, et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol. 2009;27(22):3712–22.PubMedCrossRefGoogle Scholar
  60. 60.
    Hassler MR, Elandt K, Preusser M, Lehrner J, Binder P, Dieckmann K, et al. Neurocognitive training in patients with high-grade glioma: a pilot study. J Neurooncol. 2010;97(1):109–15.PubMedCrossRefGoogle Scholar
  61. 61.
    Zucchella C, Capone A, Codella V, De Nunzio AM, Vecchione C, Sandrini G, et al. Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumour: a randomized, controlled trial. J Neurooncol. 2013;114(1):93–100.PubMedCrossRefGoogle Scholar
  62. 62.
    Yang S, Chun MH, Son YR. Effect of virtual reality on cognitive dysfunction in patients with brain tumour. Ann Rehabil Med. 2014;38(6):726–33.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Maschio M, Dinapoli L, Fabi A, Giannarelli D, Cantelmi T. Cognitive rehabilitation training in patients with brain tumour-related epilepsy and cognitive deficits: a pilot study. J Neurooncol. 2015;125:419–26.PubMedCrossRefGoogle Scholar
  64. 64.
    Lo Buono V, Corallo F, De Cola MC, Chillemi A, Grugno R, Bramanti P, et al. Effect of cognitive rehabilitation in a case of thalamic astrocytoma. Appl Neuropsychol Adult. 2016;23(4):309–12.PubMedCrossRefGoogle Scholar
  65. 65.
    Carney N, Chesnut RM, Maynard H, Mann NC, Patterson P, Helfand M. Effects of cognitive rehabilitation on outcomes for persons with traumatic brain injury: a systematic review. J Head Trauma Rehabil. 1999;14:277–307.PubMedCrossRefGoogle Scholar
  66. 66.
    Wilson BA, Herbert CM, Shiel A. Behavioural approaches in neuropsychological rehabilitation: optimising rehabilitation procedures. Hove, UK: Psychology Press; 2003.CrossRefGoogle Scholar
  67. 67.
    Wilson BA. Neuropsychological rehabilitation: theory and practice. Lisse, The Netherlands: Swets & Zeitlinger BV; 2003.CrossRefGoogle Scholar
  68. 68.
    Baddeley AD. A theory of rehabilitation without a model of learning is a vehicle without an engine: a comment on Caramazza and Hillis. Neuropsychol Rehabil. 1993;3:235–44.CrossRefGoogle Scholar
  69. 69.
    Kessels RP, de Haan EH. Implicit learning in memory rehabilitation: a meta-analysis on errorless learning and vanishing cues methods. J Clin Exp Neuropsychol. 2003;25(6):805–14.PubMedCrossRefGoogle Scholar
  70. 70.
    Hebb DO. The organization of behavior; a neuropsychological theory. New York: Wiley and Sons; 1949.Google Scholar
  71. 71.
    Robertson IH, Murre JMJ. Rehabilitation of brain damage: brain plasticity and principles of guided recovery. Psychol Bull. 1999;125(5):544–75.PubMedCrossRefGoogle Scholar
  72. 72.
    Sharma N, Classen J, Cohen LG. Neural plasticity and its contribution to functional recovery. Handb Clin Neurol. 2013;110:3–12.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Bütefisch CM. Plasticity in the human cerebral cortex: lessons from the normal brain and from stroke. Neuroscientist. 2004;10(2):163–73.PubMedCrossRefGoogle Scholar
  74. 74.
    Nudo RJ, McNeal D. Plasticity of cerebral functions. Handb Clin Neurol. 2013;110:13–21.PubMedCrossRefGoogle Scholar
  75. 75.
    Matthews PM, Honey GD, Bullmore ET. Applications of fMRI in translational medicine and clinical practice. Nat Rev Neurosci. 2006;7:732–44.PubMedCrossRefGoogle Scholar
  76. 76.
    Fisicaro RA, Jost E, Shaw K, Brennan NP, Peck KK, Holodny AI. Cortical plasticity in the setting of brain tumours. Top Magn Reson Imaging. 2016;25(1):25–30.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Desmurget M, Bonnetblanc F, Duffau H. Contrasting acute and slow-growing lesions: a new door to brain plasticity. Brain. 2007;130:898–914.PubMedCrossRefGoogle Scholar
  78. 78.
    Ghinda CD, Duffau H. Network plasticity and intraoperative mapping for personalized multimodal management of diffuse low-grade gliomas. Front Surg. 2017;4:3.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Duffau H, Capelle L. Functional recuperation following lesions of the primary somatosensory fields. Study of compensatory mechanisms. Neurochirurgie. 2001;47:557–63.PubMedGoogle Scholar
  80. 80.
    Duffau H, Capelle L, Denvil D, Sichez N, Gatignol P, Lopes M, et al. Functional recovery after surgical resection of low grade gliomas in eloquent brain: hypothesis of brain compensation. J Neurol Neurosurg Psychiatry. 2003;74:901–7.PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Heiss WD, Thiel A, Kessler J, Herholz K. Disturbance and recovery of language function: correlates in PET activation studies. Neuroimage. 2003;20(Suppl 1):S42–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Chiara Zucchella
    • 1
  1. 1.Neurology A – Verona University HospitalVeronaItaly

Personalised recommendations